Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement

Annals of the Rheumatic Diseases

Volumn 70, Issue 10, 2011, Pages 1876-1878

  Manetti, Mirko ^a   Guiducci, Serena ^a   Ceccarelli, Claudia ^a   Romano, Eloisa ^a   Bellando Randone, Silvia ^a   Conforti, Maria Letizia ^a   Ibba Manneschi, Lidia ^a   Matucci Cerinic, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 33;

ADULT; CAPILLAROSCOPY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; SYSTEMIC SCLEROSIS;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 80052510979     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.148247     Document Type: Letter

References (10)

1. Varga J., Abraham D. Systemic sclerosis: A prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-567 (Pubitemid 46348510)
2. Oboki K., Ohno T., Kajiwara N., et al. IL-33 and IL-33 receptors in host defense and diseases. Allergol Int 2010;59:143-160
3. Rankin A.L., Mumm J.B., Murphy E., et al. IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol 2010;184:1526-1535
4. Choi Y.S., Choi H.J., Min J.K., et al. Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood 2009;114:3117-3126
5. Manetti M., Ibba-Manneschi L., Liakouli V., et al. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 2010;69:598-605.
6. LeRoy E.C., Black C., Fleischmajer R., et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205 (Pubitemid 18073738)
7. Medsger T.A., Jr, Steen V.D. Classification, prognosis. In: Clements PJ, Furst DE, eds. Systemic Sclerosis. Second edition. Philadelphia, PA: Lippincott Williams & Wilkins 1996:51-79.
8. Valentini G., Matucci Cerinic M. Disease-specific quality indicators, guidelines and outcome measures in scleroderma. Clin Exp Rheumatol 2007;25(6 Suppl 47):159-162
9. Cutolo M., Sulli A., Pizzorni C., et al. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155-160 (Pubitemid 30058643)
10. Matsuyama Y., Okazaki H., Tamemoto H., et al. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J Rheumatol 2010;37:18-25.